Skip to content

Protective Effect of Electroacupuncture on Lung in Patients Undergoing General Anesthesia

Protective Effect of Electroacupuncture on Lung in Patients Undergoing General Anesthesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05019079
Enrollment
72
Registered
2021-08-24
Start date
2021-09-01
Completion date
2023-09-01
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electroacupuncture, Lung Injury, Ventilator Induced

Keywords

Electroacupuncture, Lung protection, ventilator induced lung injury

Brief summary

Objective to investigate the protective effect of preoperative electroacupuncture on lung function in patients with mechanical ventilation for more than 2 hours under general anesthesia

Detailed description

Randomized parallel control study. From September 1, 2021 to December 31, 2022, patients with mechanical ventilation time more than 2 hours will be randomly divided into electroacupuncture pretreatment group and blank control group. The blood gas index, ventilator parameters and serum inflammatory factor concentration of patients will be evaluated to evaluate whether electroacupuncture has protective effect on lung function of patients with mechanical ventilation.

Interventions

OTHERelectroacupuncture

In the electroacupuncture group, acupoints of Lieque (+), Chize (-), Sanyinjiao (-), Zusanli (+), Tanzhong (+) and Yutang (-) will be selected for electrical stimulation. Density wave will be selected, and the current intensity should be tolerated by the patients. Conventional anesthesia operation could be started after the connection of electroacupuncture, and acupuncture point stimulation will be stopped 30min later.

Sponsors

Lingling Ding
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing general anesthesia in our hospital; * Ages 18-60; * American Society of Anesthesiologists (ASA) grade ⅱ \ III , no severe respiratory, circulation, liver, kidney, coagulation function abnormalities; * Expected duration of operation \>2h; * Surgical grade 2-4; * No serious lung infection and lung disease; * Body mass index (BMI) 18\ 30 kg/m2; There are no contraindications for electroacupuncture stimulation.

Exclusion criteria

* Patients with severe circulatory or other system dysfunction; * Patients with pulmonary and one-lung ventilation; * Unwilling to cooperate with the patient; * Patients with low compliance.

Design outcomes

Primary

MeasureTime frameDescription
oxygenation indexBefore anesthesiarecord oxygenation index

Secondary

MeasureTime frameDescription
sedation score (Ramsay)during anesthesia recovery periodAssess the quality of recovery during recovery
restfulness score (DRS)during anesthesia recovery periodAssess the quality of recovery during recovery
visual analogue scale (VAS)during anesthesia recovery periodAssess the quality of recovery during recovery
Length of stay1 week after discharge, the patient's length of stay will be recorded through medical record systemAssess the quality of postoperative recovery
postoperative time in hospital1 week after discharge, the patient's postoperative time in hospital will be recorded through medical record systemAssess the quality of postoperative recovery
postoperative complications of major organsMajor organ complications during hospitalization,assessed up to 30 days after surgeryAssess the quality of postoperative recovery
mortality within 30 daysmortality within 30 days will be recordedAssess the quality of postoperative recovery
Postoperative comfort scoreduring anesthesia recovery periodAssess the quality of recovery during recovery
Expression of IL-1β in serumBefore anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-1β in serum will be detected by flow cytometryThe perioperative inflammation level will be assessed
Expression of IL-10 in serumBefore anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-10 in serum will be detected by flow cytometryThe perioperative inflammation level will be assessed
Mean arterial pressureBefore anesthesia ,2 hours after tracheal intubation , and 5minutes after tracheal intubation removalIntraoperative vital signs will be recorded
heart rateBefore anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removalIntraoperative vital signs will be recorded
BISBefore anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removalIntraoperative vital signs will be recorded
extubation timeBefore anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removalIntraoperative vital signs will be recorded
anesthesia dosageBefore anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removalIntraoperative vital signs will be recorded
Expression of IL-18 in serumBefore anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-18 in serum will be detected by flow cytometryThe perioperative inflammation level will be assessed

Contacts

Primary ContactLingling Ding, Doctor
dinglingling301@126.com+86 010 52176647
Backup ContactJiaqi Ning, bachelor
ningjiaqi95@163.com+86 010 52176647

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026